Teniposide

Teniposide is one of the newer chemotherapy drugs, and has been around, and in use for a few years. Teniposide, when prepared for use, becomes a clear, colorless liquid, and is given by intravenous route only. It is most commonly used in treatment of the following cancers:

• Acute Lymphocytic Leukemia , in relapse

• Small Cell Lung Cancer

The type and extent of a cancer will determine the method and schedule of administration of this drug. This decision is made by the medical oncologist. Teniposide is normally given once or twice weekly.

Side effects:

The degree and severity of the side effects depend on the amount and schedule of the administration of Teniposide. Following are some of the most common and significant ill effects:

• Low white blood counts

• Low platelet count

• Anemia

• Hair loss

• Liver damage

It is imperative that patients relay any side effects or problems to their medical oncologists.